About Neumodx molecular, inc.
NeuMoDx Molecular, Inc. is a leading molecular diagnostic company that offers innovative solutions for the diagnosis of infectious diseases. The company's mission is to provide accurate and reliable results to healthcare professionals and patients worldwide.
The NeuMoDx™ Molecular Systems are a family of scalable platforms that integrate the entire molecular diagnostic process from sample to result. These systems are designed to meet the needs of clinical laboratories, hospitals, and research institutions by providing high-throughput testing capabilities with minimal hands-on time.
One of the key features of NeuMoDx™ Molecular Systems is their ability to automate complex laboratory processes, including nucleic acid extraction, amplification, detection, and analysis. This automation reduces the risk of human error and increases efficiency in laboratory workflows.
The NeuMoDx™ 96 and 288 Molecular Systems are two examples of these scalable platforms that offer high-throughput testing capabilities for clinical laboratories. The NeuMoDx™ 96 system can process up to 96 samples simultaneously while the NeuMoDx™ 288 system can process up to 288 samples at once.
In addition to their scalability and automation features, NeuMoDx™ Molecular Systems also offer a wide range of assays for infectious disease testing. These assays include tests for respiratory viruses such as influenza A/B and COVID-19 as well as tests for sexually transmitted infections like chlamydia and gonorrhea.
NeuMoDx Molecular has also developed an assay for detecting antibiotic resistance genes in bacteria. This assay helps healthcare professionals identify bacterial strains that may be resistant to certain antibiotics so they can prescribe appropriate treatments.
Overall, NeuMoDx Molecular's innovative solutions have revolutionized molecular diagnostics by providing accurate results with minimal hands-on time. Their commitment to improving patient outcomes through advanced technology makes them a leader in the field of infectious disease testing.